Results 261 to 270 of about 1,949,289 (385)
Sjögren disease (SjD) is a common systemic autoimmune disorder characterized by inflammation of the exocrine glands, resulting in dryness. Patients frequently exhibit extraglandular manifestations affecting various organ systems. To date, there are no US Food and Drug Administration (FDA)‐approved disease‐modifying therapies for SjD. In this review, we
Rachael A. Gordon, Sara S. McCoy
wiley +1 more source
Enhanced recovery after surgery compliance and outcomes in an international multisurgical cohort. [PDF]
Nelson G +9 more
europepmc +1 more source
Objective The therapeutic effects of telitacicept combined with standard of care (SoC) in childhood‐onset systemic lupus erythematosus (cSLE) remain unclear. This study aims to evaluate its efficacy in comparison with belimumab combined with SoC.
Chong Luo +15 more
wiley +1 more source
An interpretative review of North American expert consensus on the clinical role of ex vivo lung perfusion (EVLP) with acellular perfusate. [PDF]
Chen WY +17 more
europepmc +1 more source
Objectives The aim of this study is to generate hypotheses about unknown drugs associated with the onset or worsening of Raynaud's phenomenon (RP) and to explore their potential pathophysiologic mechanisms through a mixed disproportionality/clustering analysis from the World Health Organization (WHO) pharmacovigilance database.
Alex Hlavaty +4 more
wiley +1 more source
The relationship between the development trajectory of symptom burden and exercise adherence during remote pulmonary rehabilitation in olderly patients with COPD. [PDF]
Feng L, Ji H, Yang QQ, Liang M.
europepmc +1 more source
A. Thomson, J. Elliott, M. Silverman
semanticscholar +1 more source

